A Methodological Approach to Measuring the Impact of TAK-003 for the Prevention of Dengue in Dourados, Brazil: Optimizing Strategies for Public Health

<b>Background/Objectives</b>: Takeda’s tetravalent dengue vaccine TAK-003 has been approved by the Brazilian regulatory agency ANVISA for dengue disease prevention in individuals aged 4 to 60 years. Dourados, in the state of Mato Grosso do Sul, became the world’s first city to implement...

Full description

Saved in:
Bibliographic Details
Main Authors: Benedetta Ghezzi, Cristina Valencia, Roberto Dias de Oliveira, Daniel Tsuha, Waldno Lucena Júnior, Alberta Di Pasquale, Morgan Mc Namara, Juliana Senra, Denise Abud, Julio Croda
Format: Article
Language:English
Published: MDPI AG 2025-01-01
Series:Vaccines
Subjects:
Online Access:https://www.mdpi.com/2076-393X/13/2/121
Tags: Add Tag
No Tags, Be the first to tag this record!